0001969223-24-000050.txt : 20240207
0001969223-24-000050.hdr.sgml : 20240207
20240207175948
ACCESSION NUMBER: 0001969223-24-000050
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20240207
DATE AS OF CHANGE: 20240207
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 24606143
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Landry Robert E
CENTRAL INDEX KEY: 0001585160
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
144
1
primary_doc.xml
144
0001585160
XXXXXXXX
LIVE
0000872589
Regeneron Pharmaceuticals, Inc.
000-19034
777 Old Saw Mill River Road
Tarrytown
NY
10591
914-847-7000
Robert Landry
Former CFO
Common Stock
UBS Financial Services Inc
1000 Harbor Blvd
3rd Floor
Weehawken
NJ
07086
2500
2375000
107943750
02/07/2024
NASDAQ
Common Stock
02/02/2024
Stock Option Exercise
Company
N
119
02/02/2024
Stock
Common Stock
01/31/2024
Stock Option Exercise
Company
N
118
01/31/2024
Stock
Common Stock
01/24/2024
Stock Option Exercise
Company
N
148
01/24/2024
Stock
Common Stock
01/23/2024
Stock Option Exercise
Company
N
324
01/23/2024
Stock
Common Stock
01/17/2024
Stock Option Exercise
Company
N
146
01/17/2024
Stock
Common Stock
01/12/2024
Stock Option Exercise
Company
N
232
01/12/2024
Stock
Common Stock
01/04/2024
Stock Option Exercise
Company
N
158
01/04/2024
Stock
Common Stock
01/03/2024
Stock Option Exercise
Company
N
412
01/03/2024
Stock
Common Stock
01/02/2024
Stock Option Exercise
Company
N
229
01/02/2024
Stock
Common Stock
12/28/2023
Stock Option Exercise
Company
N
238
12/28/2023
Stock
Common Stock
12/27/2023
Stock Option Exercise
Company
N
208
12/27/2023
Stock
Common Stock
12/13/2023
Stock Option Exercise
Company
N
277
12/13/2023
Stock
Common Stock
12/12/2023
Restricted Stock Award
Company
N
6119
12/12/2023
Stock
Y
02/07/2024
/s/ UBS Financial Services Inc, as attorney-in-fact for Robert Landry